ACTIVE SUBSTANCE / INN

PALIFERMIN

Brand name(s): Kepivance, KEPIVANCE
FDA LISTED
EMA LISTED
PRESCRIPTION
WITHDRAWN
BLA125103
Mucositis
ACTIVE SUBSTANCE
Palifermin
REGULATORS
FDA · EMA
SPONSORS / MAH
Swedish Orphan Biovitrum AB (publ), BIOVITRUM AB
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
KEPIVANCEBLA125103BIOVITRUM ABPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
KepivanceSwedish Orphan Biovitrum AB (publ)Withdrawn25/10/2005Mucositis

FULL INTELLIGENCE ON PALIFERMIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →